BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7172873)

  • 1. [An evaluation of the determination of serum conjugated cholic acid in patients with hepatobiliary diseases].
    Fan SL; Li ZJ; Chen WY
    Zhonghua Nei Ke Za Zhi; 1982 Jul; 21(7):386-9. PubMed ID: 7172873
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reassessment of conjugated cholic acid in the serum of patients with hepatic, biliary and pancreatic diseases].
    Yuan AL; Liu WW; Luo YH
    Zhonghua Nei Ke Za Zhi; 1985 Jul; 24(7):398-400, 445-6. PubMed ID: 4053801
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum desialylated glycoproteins in patients with hepatobiliary dysfunction.
    Marshall JS; Williams S; Jones P; Hepner GW
    J Lab Clin Med; 1978 Jul; 92(1):30-7. PubMed ID: 96195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of serum levels of conjugated cholic acid in the diagnosis of liver disease (author's transl)].
    Wildgrube HJ; Stang H; Winkler M; Mauritz G
    Dtsch Med Wochenschr; 1982 Aug; 107(33):1235-7. PubMed ID: 7106004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic acid contents of glycoprotein and seromucoid in liver diseases.
    Kaniak J; Mejbaum-Katzenelenbogen W; Jelewska-Kaniakowa Z; Kudrewicz-Hubicka Z; Kowal-Gierczak B
    Pol Med J; 1970; 9(5):1076-81. PubMed ID: 5510277
    [No Abstract]   [Full Text] [Related]  

  • 6. [Activity of blood serum lactate dehydrogenase and its isoenzymes in liver and biliary tract diseases].
    Podil'chak EM
    Ter Arkh; 1972 Jul; 44(7):46-8. PubMed ID: 5069977
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative determination of non-sulfated bile acids in the serum of patients with hepatobiliary diseases by mass fragmentography.
    Takikawa H; Beppu T; Seyama Y; Wada T
    Gastroenterol Jpn; 1983 Jun; 18(3):246-51. PubMed ID: 6307803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical value of analysis of serum bile acid concentration].
    Linnet K
    Ugeskr Laeger; 1981 Aug; 143(36):2294-7. PubMed ID: 7029843
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of blood ammonia level in liver diseases].
    Engelmann L
    Z Gesamte Inn Med; 1970 Dec; 25(23):1049-55. PubMed ID: 4104436
    [No Abstract]   [Full Text] [Related]  

  • 10. [The angiotensinase activity of -L-asparaginyl aminopeptidase in the serum of normal subjects, in patients with hepatobiliary diseases and during pregnancy].
    Kaulhausen H; Pfeiffer P; Breuer H
    Z Klin Chem Klin Biochem; 1972 Feb; 10(2):51-5. PubMed ID: 4347073
    [No Abstract]   [Full Text] [Related]  

  • 11. [Haptoglobin and ceruloplasmin in liver and biliary tract diseases].
    Prellwitz W; Hammar CH; Dudeck J
    Dtsch Med Wochenschr; 1968 Jun; 93(26):1277-81. PubMed ID: 5653473
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sialic acid of glycoproteins and seromucoid in liver diseases].
    Kaniak J; Mejbaum-Katzenellenbogen ; Jelewska-Kaniakowa Z; Kudrewicz-Hubicka Z; Kowal-Gierczak B
    Pol Tyg Lek; 1969 Dec; 24(51):1953-5. PubMed ID: 5365679
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fundamental and clinical study of the Eiken Cholic Acid RIA Kit for determining serum cholic acid].
    Noguchi M; Nakajima K; Fukuda Y; Adachi H; Yoshii M; Kohno S; Nakano H; Honda T; Kawaguchi Y; Torizuka K
    Kaku Igaku; 1982 Sep; 19(8):1249-57. PubMed ID: 7154421
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases.
    Makino I; Hashimoto H; Shinozaki K; Yoshino K; Nakagawa S
    Gastroenterology; 1975 Mar; 68(3):545-53. PubMed ID: 1112456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bile acids in the serum of patients with extrahepatic cholestasis with chronic liver diseases].
    Erb W; Schreiber J; Walczak M
    Z Gastroenterol; 1973 May; 11(4):279-88. PubMed ID: 4803425
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the action of C-reactive proteins in relation to current liver tests].
    Renger F; Kanehl R; Kanehl E
    Acta Hepatosplenol; 1965; 12(6):337-51. PubMed ID: 5868476
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of serum levels of tryptophan in hepatobiliary disease.
    Yoshida K; Hirayama C
    Clin Chim Acta; 1980 Feb; 101(2-3):235-40. PubMed ID: 6244122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum bile acids in hepatobiliary disease].
    Esquivel López A; González Espinola G; Gutiérrez Nava R; García Arreola RM
    Rev Gastroenterol Mex; 1982; 47(1):9-12. PubMed ID: 7100761
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of plasma fibrinolytic activity in chronic disorders of the liver and biliary tract].
    Pstruzinová H; Jablonská M; Richter V; Pstruzina J
    Sb Lek; 1971 Apr; 73(4):89-98. PubMed ID: 5552779
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behavior of the serum electrolytes sodium and potassium in patients with cholelithiasis with reference to pathologic changes in the liver].
    Schmauss AK; Gerloff D; Poley FW
    Z Gesamte Inn Med; 1971 May; 26(10):327-31. PubMed ID: 5131401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.